Lavanchy D: Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004, 11: 97-107. 10.1046/j.1365-2893.2003.00487.x.
Article
CAS
PubMed
Google Scholar
Alam MM, Zaidi SZ, Malik SA, Naeem A, Shaukat S, Sharif S, Angez M, Khan A, Butt JA: Serology based disease status of Pakistani population infected with Hepatitis B virus. BMC Infect Dis. 2007, 7: 64-10.1186/1471-2334-7-64.
Article
PubMed
PubMed Central
Google Scholar
Zeng Z, Guan L, An P, Sun S, O'Brien SJ, Winkler CA, HBV study consortium: A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population. BMC Infect Dis. 2008, 8: 1-10.1186/1471-2334-8-1.
Article
PubMed
PubMed Central
Google Scholar
Maddrey W: Hepatitis B: an important public health issue. J Med Virol. 2000, 61: 362-366. 10.1002/1096-9071(200007)61:3<362::AID-JMV14>3.0.CO;2-I.
Article
CAS
PubMed
Google Scholar
Wei L: Natural history of chronic hepatitis B virus infection: what determines prognosis after cirrhotic decompensation?. J Gastroenterol Hepatol. 2008, 23: 1631-1632. 10.1111/j.1440-1746.2008.05576.x.
Article
PubMed
Google Scholar
Liaw YF, Leung N, Guan R, Lau GK, Merican I, McCaughan G, Gane E, Kao JH, Omata M, Asian-Pacific consensus update working party on chronic hepatitis B: Asian-Pacific consensus ststement on the management of chronic hepatitis B: a 2005 update. Liver Int. 2005, 25: 472-489. 10.1111/j.1478-3231.2005.01134.x.
Article
PubMed
Google Scholar
Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, Dixon JS, Gray DF, Sabbat J, Cirrhosis Asian Lamivudine Multicentre Study Group: Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004, 351: 1521-1531. 10.1056/NEJMoa033364.
Article
CAS
PubMed
Google Scholar
Bravo AA, Sheth SG, Chopra S: Liver biopsy. N Engl J Med. 2001, 344: 495-500. 10.1056/NEJM200102153440706.
Article
CAS
PubMed
Google Scholar
Narasimhan G, Sargios TN, Kalakuntla R, Homel P, Clain DJ, Theise ND, Bodenheimer HC, Min AD: Treatment rates in patients with chronic hepatitis C after liver biopsy. J Viral Hepat. 2006, 13: 783-786. 10.1111/j.1365-2893.2006.00763.x.
Article
CAS
PubMed
Google Scholar
Piccinino F, Sagnelli E, Pasquale G, Giusti G: Complications following percutaneous liver biopsy: A multicentre retrospective study on 68,276 biopsies. J Hepatol. 1986, 2: 165-173. 10.1016/S0168-8278(86)80075-7.
Article
CAS
PubMed
Google Scholar
Siddique I, El-Naga HA, Madda JP, Memon A, Hasan F: Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol. 2003, 38: 427-432. 10.1080/00365520310000825.
Article
CAS
PubMed
Google Scholar
Wai CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, Mak B, Oo AM, Lim SG: Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver Int. 2006, 26: 666-672. 10.1111/j.1478-3231.2006.01287.x.
Article
PubMed
Google Scholar
Mohamadnejad M, Montazeri G, Fazlollahi A, Zamani F, Nasiri J, Nobakht H, Forouzanfar MH, Abedian S, Tavangar SM, Mohamadkhani A, Ghoujeghi F, Estakhri A, Nouri N, Farzadi Z, Najjari A, Malekzadeh R: Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease. Am J Gastroenterol. 2006, 101: 2537-2545.
Article
PubMed
Google Scholar
Fung J, Lai CL, Fong DY, Yuen JC, Wong DK, Yuen MF: Correlation of liver biochemistry with liver stiffess in chronic hepatitis B and development of a predictive model for liver fibrosis. Liver International. 2008, 28: 1408-1416. 10.1111/j.1478-3231.2008.01784.x.
Article
PubMed
Google Scholar
Ngo Y, Benhamou Y, Thibault V, Ingiliz P, Munteanu M, Lebray P, Thabut D, Morra R, Messous D, Charlotte F, Imbert-Bismut F, Bonnefont-Rousselot D, Moussalli J, Ratziu V, Poynard T: An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load. PloS One. 2008, 2 (3): e2573-10.1371/journal.pone.0002573.
Article
Google Scholar
Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, Wan MB, Chen CW, Wang JY, Cai X, Gao CF, Zhou XQ: Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology. 2005, 42: 1437-1445. 10.1002/hep.20960.
Article
PubMed
Google Scholar
Hui AY, Chan HL, Wong VW, Liew CT, Chim AM, Chan FK, Sung JJ: Identification of chronic hepatitis B patients without signification liver fibrosis by a simple noninvasive model. Am J Gastroenterol. 2005, 100: 616-623. 10.1111/j.1572-0241.2005.41289.x.
Article
PubMed
Google Scholar
Lok AS, McMahon BJ: Chronic hepatitis B. Hepatology. 2007, 45: 507-539. 10.1002/hep.21513.
Article
CAS
PubMed
Google Scholar
Green M, Bjork J, Forberg J, Ekelund U, Edenbrandt L, Ohlsson M: Comparison between neural networks and multiple logistic regression to predict acute coronary syndrome in the emergency room. Artif Intell Med. 2006, 38: 305-318. 10.1016/j.artmed.2006.07.006.
Article
PubMed
Google Scholar
Abbod MF, Catto JW, Linkens DA, Hamdy FC: Application of artificial intelligence to the management of urological cancer. J Urol. 2007, 178: 1150-1156. 10.1016/j.juro.2007.05.122.
Article
PubMed
Google Scholar
Wang CH, Mo LR, Lin RC, Kuo JJ, Chang KK, Wu JJ: Artificial neural network model is superior to logistic regression model in predicting treatment outcomes of interferon-based combination therapy in patients with chronic hepatitis C. Intervirology. 2008, 51: 14-20. 10.1159/000118791.
Article
CAS
PubMed
Google Scholar
Piscaglia F, Cucchetti A, Benlloch S, Vivarelli M, Berenguer J, Bolondi L, Pinna AD, Berenguer M: Prediction of significant fibrosis in hepatitis C virus infected liver transplant recipients by artificial neural network analysis of clinical factors. Eur J Gastroenterol Hepatol. 2006, 18: 1255-1261. 10.1097/01.meg.0000243885.55562.7e.
Article
PubMed
Google Scholar
Lampinen J, Vehtati A: Bayesian approach for neural networks-review and case studies. Neural Netw. 2001, 14: 257-274. 10.1016/S0893-6080(00)00098-8.
Article
CAS
PubMed
Google Scholar
Bedossa P, Poynard T: An algorithm for grading of activity in chronic hepatitis C. The METAVIR co-operative study group. Hepatology. 1996, 24: 289-293. 10.1002/hep.510240201.
Article
CAS
PubMed
Google Scholar
Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, Messous D, Charlotte F, Di Martino V, Benhamou Y, Poynard T: Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol. 2003, 39: 222-230. 10.1016/S0168-8278(03)00171-5.
Article
CAS
PubMed
Google Scholar
Fish KE, Blodgett JG: A visual method for determining variable importance in an artificial neural network model: an empirical benchmark study. J Targ Meas Anal Market. 2003, 11: 244-254. 10.1057/palgrave.jt.5740081.
Article
Google Scholar
Dayhoff JE, Deleo JM: Artificial neural network-Opening the black box. Cancer. 2001, 91: 1616-1635. 10.1002/1097-0142(20010415)91:8+<1615::AID-CNCR1175>3.0.CO;2-L.
Article
Google Scholar
Dienstag JL, Goldin RD, Heathcote EJ, Hann HW, Woessner M, Stephenson SL, Gardner S, Gray DF, Schiff ER: Histological outcome during long-term lamivudine therapy. Gastroenterology. 2003, 124: 105-117. 10.1053/gast.2003.50013.
Article
CAS
PubMed
Google Scholar
Lin CS, Chang CS, Yang SS, Yeh HZ, Lin CW: Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma. Internal Med. 2008, 47: 569-575. 10.2169/internalmedicine.47.0595.
Article
Google Scholar
Zhang YX, Wu WJ, Zhang YZ, Feng YL, Zhou XX, Pan Q: Noninvasive assessment of liver fibrosis with combined serum aminotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B. World of Gastroenterol. 2008, 14: 7117-7121. 10.3748/wjg.14.7117.
Article
Google Scholar
Yao XQ, Zhu HQ, She ZS: A dynamic Bayesian network approach to protein secondary structure prediction. BMC Bioinformatics. 2008, 9: 49-61. 10.1186/1471-2105-9-49.
Article
PubMed
PubMed Central
Google Scholar
Halfon P, Munteanu M, Poynard T: FibroTest-ActiTest as a non-invasive marker of liver fibrosis. Gastroenterol Clin Biol. 2008, 32: 22-39. 10.1016/S0399-8320(08)73991-5.
Article
PubMed
Google Scholar
Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, Ratziu V, Mercadier A, Benhamou Y, Hainque B: Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol. 2004, 3: 8-19. 10.1186/1476-5926-3-8.
Article
PubMed
PubMed Central
Google Scholar
Sebastiani G, Vario A, Guido M, Alberti A: Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol. 2007, 13: 525-731.
Article
PubMed
PubMed Central
Google Scholar
Shin WG, Park SH, Jang MK, Hahn TH, Kim JB, Lee MS, Kim DJ, Jun SY, Park CK: Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig Liver Dis. 2008, 40: 267-274. 10.1016/j.dld.2007.10.011.
Article
CAS
PubMed
Google Scholar
Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J: Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med. 2004, 140: 189-202.
Article
PubMed
Google Scholar
Poynard T, Halfon P, Castera L, Munteanu M, Imbert-Bismut F, Ratziu V, Benhamou Y, Bourliere M, de Ledinghen V, FibroPaca Group: Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages. Clinical Chemistry. 2007, 53: 1615-1622. 10.1373/clinchem.2007.085795.
Article
CAS
PubMed
Google Scholar